与癌症相关的静脉血栓塞栓症的抗血栓治疗
Giacinto Di Leo1, Costanza Agata Bordonaro1, Davide Capodanno2
1Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco" University of, Catania, Italy.
概括
与癌症相关的静脉血栓栓塞 (VTE) 是癌症患者的主要死亡原因. 目前的治疗方法,如低分子量肝素和直接口服抗凝剂有局限性,新疗法显示出希望.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与癌症相关的静脉血栓栓塞 (VTE) 是瘤学中常见的,危及生命的并发症,是癌症死亡的第二大原因.
- 致病性涉及瘤前凝活性,全身炎症和前血栓性抗癌疗法,在特定癌症和晚期癌症中风险更高.
研究的目的:
- 审查与癌症相关的VTE的当前管理,包括既定和新兴的治疗策略.
- 为了突出挑战和未满足的需要在抗凝血治疗的癌症患者经历VTE.
- 讨论新药的潜力,如XI因子抑制剂,改善VTE管理.
主要方法:
- 关于与癌症相关的VTE管理的当前文献和指导方针的审查.
- 对低分子量肝素 (LMWHs) 和直接口服抗凝剂 (DOACs) 的疗效和限制的分析.
- 探索新的治疗点和正在进行的临床试验,包括XI因子抑制.
主要成果:
- 慢性血大血压和慢性血大血压是第一线选择,但存在诸如出血风险,药物相互作用和特定患者群体的治疗 (例如血栓塞缩小症) 等挑战.
- 尽管服用抗凝血药和坚持治疗,但复发性血栓形成仍然存在重大未满足的需求.
- 新兴的策略,特别是XI因子抑制,显示出提高疗效的潜力,降低出血风险.
结论:
- 与癌症相关的静脉瘤治疗需要个性化的方法,平衡血栓形成和出血风险.
- 需要新的抗凝血策略来应对持续存在的挑战,并改善这种脆弱患者群体的治疗结果.
- 持续的研究,包括对abelacimab等药物的试验,对于完善治疗方案至关重要.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
388
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
388
01:30Venous Thrombosis IV: Nursing Management
278
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
278
01:30Venous Thrombosis I: Introduction
504
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
504
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
362
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
362
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
01:27Pulmonary Embolism III: Nursing Management
470
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
470